https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-testing-a-new-way-of-managing-fever-linked-to-dabrafenib-and-trametinib-for-melanoma-skin
A study testing a new way of managing fever linked to dabrafenib and trametinib for melanoma skin...
This study is looking at the combination of dabrafenib and trametinib for melanoma and how to manage the fever it can cause.
a studynew waymanaging fevertestinglinked
https://research.luriechildrens.org/en/clinical-studies-search/trametinib-and-everolimus-for-the-treatment-of-pediatric-and-young-adult-patients-with-recurrent-low-grade-gliomas-pnoc021/
Trametinib and Everolimus for the Treatment of Pediatric and Young Adult Patients With Recurrent...
for theyoung adulttrametinibeverolimustreatment
https://esc365.escardio.org/journal/68971
ESC 365 - Successful treatment of refractory chylothorax with MEK inhibitor trametinib in a child...
Access European Heart Journal - Case Reports article on on ESC 365.
in aescsuccessfultreatmentrefractory
https://alentris.org/products/t/trametinib/trametinib-impurity-12/
Trametinib Impurity 12 - API Impurities - Alentris Research Pvt. Ltd.
trametinibimpurityapiimpuritiesresearch
https://adisinsight.springer.com/drugsafety/803575776?error=cookies_not_supported&code=490dde37-0e5f-4b38-b293-4b4ae53f2bc2
Trametinib - AdisInsight
A 28-year-old man developed acneiform rash, paronychia and asthenia during an off-label treatment with trametinib for agminated benign vascular tumour.The man
trametinib
https://curemydisease.com/studies/long-term-safety-study-of-dabrafenib-trametinib-nct03340506-293
Long-Term Safety Study of Dabrafenib/Trametinib NCT03340506
This roll-over study tracks long-term safety of dabrafenib/trametinib in patients with melanoma, lung cancer, or other solid tumors who benefited from prior...
long termsafetystudydabrafenibtrametinib
https://primedicin.com.br/principioativo/trametinib/
Arquivo para Trametinib - Primedicin
arquivoparatrametinib
https://www.pocn.com/fda-approves-dabrafenib-trametinib-for-braf-v600e-tumors/
FDA Approves Dabrafenib/Trametinib for BRAF V600E Tumors - POCN
Apr 11, 2024 - The combination of dabrafenib and trametinib received accelerated FDA approval [...]
fdaapprovesdabrafenibtrametinibtumors
https://contratos-publicos.comunidad.madrid/contrato-publico/medicamentos-ribociclib-trametinib-eltrombopag-dabrafenib-nilotinib-lapatinib
Medicamentos: Ribociclib, Trametinib, Eltrombopag, Dabrafenib, Nilotinib, Lapatinib y Pazopanib...
Medicamentos: Ribociclib, Trametinib, Eltrombopag, Dabrafenib, Nilotinib, Lapatinib y Pazopanib para el HUP
medicamentostrametinibeltrombopagdabrafenib
https://ispnlibrary.org/article/trametinib-for-orbital-plexiform-neurofibromas-in-young-children-with-neurofibromatosis-type-1/
Trametinib for Orbital Plexiform Neurofibromas in Young Children with Neurofibromatosis Type 1 -...
Apr 20, 2026 - In a case series of five young children (mean age ~27 months) with NF1-associated orbital plexiform neurofibromas, trametinib was administered for a median of...
young childrentrametiniborbitalneurofibromatosistype
https://ascopost.com/news/november-2022/dabrafenib-in-combination-with-trametinib-for-unresectable-or-metastatic-solid-tumors-with-braf-v600e-mutation/
Dabrafenib in Combination With Trametinib for Unresectable or Metastatic Solid Tumors With BRAF...
On June 22, 2022, dabrafenib in combination with trametinib was granted accelerated approval for treatment of adult and pediatric patients (aged 6 and older)...
solid tumorsdabrafenibcombinationtrametinibmetastatic
https://www.pacb.com/publications/a-personalized-platform-identifies-trametinib-plus-zoledronate-for-a-patient-with-kras-mutant-metastatic-colorectal-cancer/
A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant...
Colorectal cancer remains a leading source of cancer mortality worldwide. Initial response is often followed by emergent resistance that is poorly responsive...
for patientpersonalizedplatformtrametinibplus
https://database.inahta.org/article/32417
[Dabrafenib and trametinib (ma
dabrafenibtrametinib
https://www.survivornet.com/clinical-trials/melanoma/nivolumab-with-trametinib-and-dabrafenib-or-encorafenib-and-binimetinib-in-treating-patients-with-braf-mutated-metastatic-or-unresectable-stage-iii-iv-melanoma/
Melanoma Clinical Trial: Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib...
Jun 6, 2024 - Melanoma - A Phase II Study of the TRIplet Combination of Dabrafenib, Nivolumab, and Trametinib in Patients With Metastatic Melanoma (TRIDeNT)
clinical trialmelanomatrametinibdabrafenib
https://edoc.mdc-berlin.de/id/eprint/19621/
MEK inhibitor trametinib attenuates neuroinflammation and cognitive deficits following traumatic...
mekinhibitortrametinibneuroinflammationcognitive
https://www.horizonscangeneesmiddelen.nl/geneesmiddelen/dabrafenib-trametinib-0?versie=versie-1
Dabrafenib / trametinib | Horizonscan geneesmiddelen
Treatment of differentiated thyroid cancer (DTC)
horizonscan geneesmiddelendabrafenibtrametinib
https://augusta.elsevierpure.com/en/publications/targeting-protein-arginine-methyltransferase-5-sensitizes-gliobla/
Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinib - Augusta...
targetingproteinarginineglioblastomatrametinib
https://pharsight.greyb.com/ingredient/trametinib-dimethyl-sulfoxide-patent-expiration
Drug Patents containing Trametinib Dimethyl Sulfoxide
Find out details of Trametinib Dimethyl Sulfoxide patent expiration, the company that first launched it, other drugs containing it as an active ingredient, and...
dimethyl sulfoxidedrugpatentscontainingtrametinib
https://zorgkrant.nl/management-en-beleid/10613-combinatietherapie-dabrafenib-en-trametinib-bij-huidkanker-niet-in-basispakket
Combinatietherapie dabrafenib en trametinib bij huidkanker niet in basispakket
Het Zorginstituut kan op basis van de beschikbare onderzoeken niet vaststellen of deze combinatietherapie kosteneffectief is
combinatietherapiedabrafenibtrametinibbijhuidkanker
https://pure.psu.edu/en/publications/impact-of-trametinib-on-the-neuropsychological-profile-of-nf1-pat/
Impact of trametinib on the neuropsychological profile of NF1 patients - Penn State
on thepenn stateimpacttrametinibneuropsychological